{
  "analysis_mode": "HISTORICAL_ONLY",
  "report_version": "5.0",
  "symbol": "TRLS.L",
  "generated_at": "2026-02-05T22:17:20.196928+00:00",
  "comprehensive_apex": {
    "score": 51,
    "rating": "MODERATE",
    "color": "#f59e0b",
    "calculation": "(57\u00d725% + 60\u00d720% + 68.9\u00d730% + 39\u00d725%) \u00d7 0.9 = 51",
    "components": {
      "setup": {
        "score": 57,
        "weight": 0.25
      },
      "trust": {
        "score": 60,
        "weight": 0.2
      },
      "panic": {
        "score": 68.9,
        "weight": 0.3
      },
      "compression": {
        "score": 39,
        "weight": 0.25
      }
    },
    "timing": {
      "regime": "EARLY_BUILD",
      "multiplier": 0.9
    }
  },
  "top_card": {
    "ticker": "TRLS.L",
    "company_name": "Trellus Health plc",
    "sector": "Healthcare",
    "market_cap_gbp": 1174804,
    "days_active": 34,
    "apex_score_100": 57,
    "confidence_score_100": 60,
    "panic_score_100": 68.9,
    "cc_score_100": 39,
    "ai_final_score_25": 11,
    "ai_strength": "MODERATE",
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 57/100 opportunity score",
    "overall_score_100": 56
  },
  "enrichment": {
    "company_info": {
      "name": "Trellus Health plc",
      "sector": "Healthcare",
      "industry": "Health Information Services",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 1174804,
      "current_close_price": 0.65
    },
    "basics": {
      "ticker": "TRLS.L",
      "current_price": 0.65,
      "ath": 78.0,
      "atl": 0.301,
      "ath_date": "2021-06-15",
      "atl_date": "2025-12-31",
      "week_52_high": 3.1,
      "week_52_low": 0.301,
      "week_52_high_date": "2025-02-26",
      "week_52_low_date": "2025-12-31",
      "drawdown_from_ath_pct": 99.17,
      "data_start": "2021-05-28",
      "data_end": "2026-02-05",
      "total_bars": 1185
    },
    "latest_signal": {
      "date": "2026-01-02",
      "scan_date": "2026-01-26",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "price": 0.4,
      "drawdown_pct": 92.59,
      "ai_score": 9.0,
      "rsi": 12.5,
      "cycle_position": 0.1984,
      "holding_period_days": 34,
      "current_pnl_pct": 62.5,
      "rally_state": "pulling_back",
      "distance_from_high_pct": -61.19,
      "Rally_Count": 1,
      "days_since_last_high": 16,
      "last_high_date": "2026-01-20",
      "lock_in_reached": true,
      "lock_in_date": "2026-01-20",
      "best_rally_pct": 318.75
    },
    "best_historical_signal": {
      "signal_date": "2024-11-28",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "entry_price": 0.625,
      "peak_price": 5.4,
      "peak_date": "2025-01-15",
      "rally_pct": 764.0,
      "days_to_peak": 48,
      "ai_score": 11.0
    },
    "all_historical_signals": [
      {
        "signal_id": "TRLS.L_2022-06-29",
        "signal_date": "2022-06-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 14.0,
        "current_price": 0.922,
        "current_return_pct": -93.41,
        "best_rally_pct": 0.0,
        "best_rally_date": "2022-06-30",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1307,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-01",
        "signal_date": "2022-07-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 13.25,
        "current_price": 0.922,
        "current_return_pct": -93.04,
        "best_rally_pct": 1.89,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1305,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-04",
        "signal_date": "2022-07-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 13.25,
        "current_price": 0.922,
        "current_return_pct": -93.04,
        "best_rally_pct": 1.89,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1302,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-05",
        "signal_date": "2022-07-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 13.25,
        "current_price": 0.922,
        "current_return_pct": -93.04,
        "best_rally_pct": 1.89,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1301,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-06",
        "signal_date": "2022-07-06",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.5,
        "current_price": 0.922,
        "current_return_pct": -91.98,
        "best_rally_pct": 17.39,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1300,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-08",
        "signal_date": "2022-07-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 10.75,
        "current_price": 0.922,
        "current_return_pct": -91.42,
        "best_rally_pct": 25.58,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1298,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-12",
        "signal_date": "2022-07-12",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 10.25,
        "current_price": 0.922,
        "current_return_pct": -91.0,
        "best_rally_pct": 31.71,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1294,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-27",
        "signal_date": "2022-07-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 8.0,
        "current_price": 0.922,
        "current_return_pct": -88.48,
        "best_rally_pct": 68.75,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1279,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-28",
        "signal_date": "2022-07-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.0,
        "current_price": 0.922,
        "current_return_pct": -89.76,
        "best_rally_pct": 50.0,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1278,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-07-29",
        "signal_date": "2022-07-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.0,
        "current_price": 0.922,
        "current_return_pct": -89.76,
        "best_rally_pct": 50.0,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1277,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-08-19",
        "signal_date": "2022-08-19",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.5,
        "current_price": 0.922,
        "current_return_pct": -87.71,
        "best_rally_pct": 80.0,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1256,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-08-24",
        "signal_date": "2022-08-24",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 7.25,
        "current_price": 0.922,
        "current_return_pct": -87.28,
        "best_rally_pct": 86.21,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1251,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-08-25",
        "signal_date": "2022-08-25",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.25,
        "current_price": 0.922,
        "current_return_pct": -87.28,
        "best_rally_pct": 86.21,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1250,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-08-26",
        "signal_date": "2022-08-26",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 7.25,
        "current_price": 0.922,
        "current_return_pct": -87.28,
        "best_rally_pct": 86.21,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1249,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-09-26",
        "signal_date": "2022-09-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.129,
        "current_price": 0.922,
        "current_return_pct": -87.07,
        "best_rally_pct": 89.37,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1218,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2022-09-30",
        "signal_date": "2022-09-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.25,
        "current_price": 0.922,
        "current_return_pct": -87.28,
        "best_rally_pct": 86.21,
        "best_rally_date": "2022-10-06",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -93.17,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1214,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2023-01-17",
        "signal_date": "2023-01-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.25,
        "current_price": 0.922,
        "current_return_pct": -90.03,
        "best_rally_pct": -0.54,
        "best_rally_date": "2023-09-20",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1105,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2023-01-18",
        "signal_date": "2023-01-18",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 8.85,
        "current_price": 0.922,
        "current_return_pct": -89.58,
        "best_rally_pct": 3.95,
        "best_rally_date": "2023-09-20",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -89.98,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1104,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2023-02-14",
        "signal_date": "2023-02-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.5,
        "current_price": 0.922,
        "current_return_pct": -87.71,
        "best_rally_pct": 22.67,
        "best_rally_date": "2023-09-20",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -89.98,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 1077,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-04-16",
        "signal_date": "2024-04-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.75,
        "current_price": 0.922,
        "current_return_pct": -47.31,
        "best_rally_pct": 182.86,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 650,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-05-24",
        "signal_date": "2024-05-24",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.65,
        "current_price": 0.922,
        "current_return_pct": -44.12,
        "best_rally_pct": 200.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 612,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-05-30",
        "signal_date": "2024-05-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.45,
        "current_price": 0.922,
        "current_return_pct": -36.41,
        "best_rally_pct": 241.38,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 606,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-06-03",
        "signal_date": "2024-06-03",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.45,
        "current_price": 0.922,
        "current_return_pct": -36.41,
        "best_rally_pct": 241.38,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 602,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-06-17",
        "signal_date": "2024-06-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.4,
        "current_price": 0.922,
        "current_return_pct": -34.14,
        "best_rally_pct": 253.57,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 588,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-06-18",
        "signal_date": "2024-06-18",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.3,
        "current_price": 0.922,
        "current_return_pct": -29.08,
        "best_rally_pct": 280.77,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 587,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-08-09",
        "signal_date": "2024-08-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.25,
        "current_price": 0.922,
        "current_return_pct": -26.24,
        "best_rally_pct": 296.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 535,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-08-12",
        "signal_date": "2024-08-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.3,
        "current_price": 0.922,
        "current_return_pct": -29.08,
        "best_rally_pct": 280.77,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 532,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-08-16",
        "signal_date": "2024-08-16",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.25,
        "current_price": 0.922,
        "current_return_pct": -26.24,
        "best_rally_pct": 296.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 528,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-08-20",
        "signal_date": "2024-08-20",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.15,
        "current_price": 0.922,
        "current_return_pct": -19.83,
        "best_rally_pct": 330.43,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 524,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-08-27",
        "signal_date": "2024-08-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.1,
        "current_price": 0.922,
        "current_return_pct": -16.18,
        "best_rally_pct": 350.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 517,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-09-26",
        "signal_date": "2024-09-26",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.05,
        "current_price": 0.922,
        "current_return_pct": -12.19,
        "best_rally_pct": 371.43,
        "best_rally_date": "2025-01-14",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 487,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-10-17",
        "signal_date": "2024-10-17",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.63,
        "current_price": 0.922,
        "current_return_pct": 46.35,
        "best_rally_pct": 685.71,
        "best_rally_date": "2025-01-14",
        "rally_state": "pulling_back",
        "Rally_Count": 6,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 466,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-10-29",
        "signal_date": "2024-10-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.675,
        "current_price": 0.922,
        "current_return_pct": 36.59,
        "best_rally_pct": 633.33,
        "best_rally_date": "2025-01-14",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 454,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-11-28",
        "signal_date": "2024-11-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.922,
        "current_return_pct": 47.52,
        "best_rally_pct": 692.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 424,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-11-29",
        "signal_date": "2024-11-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.922,
        "current_return_pct": 47.52,
        "best_rally_pct": 692.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 423,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2024-12-03",
        "signal_date": "2024-12-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.922,
        "current_return_pct": 47.52,
        "best_rally_pct": 692.0,
        "best_rally_date": "2025-01-14",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -81.37,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 419,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-06-09",
        "signal_date": "2025-06-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.95,
        "current_price": 0.922,
        "current_return_pct": -2.95,
        "best_rally_pct": 76.32,
        "best_rally_date": "2026-01-20",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 231,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-06-10",
        "signal_date": "2025-06-10",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.9,
        "current_price": 0.922,
        "current_return_pct": 2.44,
        "best_rally_pct": 86.11,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 230,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-06-24",
        "signal_date": "2025-06-24",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.922,
        "current_return_pct": 47.52,
        "best_rally_pct": 168.0,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 216,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-06-25",
        "signal_date": "2025-06-25",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.65,
        "current_price": 0.922,
        "current_return_pct": 41.85,
        "best_rally_pct": 157.69,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 215,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-07-09",
        "signal_date": "2025-07-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.65,
        "current_price": 0.922,
        "current_return_pct": 41.85,
        "best_rally_pct": 157.69,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 201,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-07-22",
        "signal_date": "2025-07-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.6,
        "current_price": 0.922,
        "current_return_pct": 53.67,
        "best_rally_pct": 179.17,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 188,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-09-08",
        "signal_date": "2025-09-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.5,
        "current_price": 0.922,
        "current_return_pct": 84.4,
        "best_rally_pct": 235.0,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 140,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-11-20",
        "signal_date": "2025-11-20",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.525,
        "current_price": 0.922,
        "current_return_pct": 75.62,
        "best_rally_pct": 219.05,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -44.96,
        "days_since_last_high": 14,
        "lock_in_reached": true,
        "age_days": 67,
        "status": "historical"
      },
      {
        "signal_id": "TRLS.L_2025-12-31",
        "signal_date": "2025-12-31",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.375,
        "current_price": 0.65,
        "current_return_pct": 73.33,
        "best_rally_pct": 346.67,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -61.19,
        "days_since_last_high": 16,
        "lock_in_reached": true,
        "age_days": 36,
        "status": "active"
      },
      {
        "signal_id": "TRLS.L_2026-01-02",
        "signal_date": "2026-01-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.4,
        "current_price": 0.65,
        "current_return_pct": 62.5,
        "best_rally_pct": 318.75,
        "best_rally_date": "2026-01-20",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -61.19,
        "days_since_last_high": 16,
        "lock_in_reached": true,
        "age_days": 34,
        "status": "active"
      }
    ],
    "stats": {
      "total_signals": 46,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 253.38,
      "median_rally_pct": 243.33,
      "best_rally_pct": 764.0,
      "worst_rally_pct": 4.32
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-05 20:04:48 UTC",
    "volatility": {
      "atr_normalized": 8.75,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "DOWNTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 57/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 1 rallies, 319% best run"
    ],
    "main_risk": "Confidence 60/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "TRLS.L",
      "latest": [
        {
          "title": "Holding(s) in Company",
          "date": "3rd Feb 2026",
          "announcement_date": "3rd Feb 2026",
          "release_time": "5:37 pm",
          "source": "RNS",
          "content": "Today 17:37\nRNS Number : 5918R\nTrellus Health PLC\n03 February 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nTrellus Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nX\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nMarla C. Dubinsky\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n02/02/2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n02/02/2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n4.8416%\n0\n4.8416%\n8,750,000\nPosition of previous notification (if\napplicable)\n5.4176%\n0\n5.4176%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BNNFM402\n8,750,000\n4.8412%\nSUBTOTAL 8. A\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nx\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nMarla C. Dubinsky\n4.8142%\n0.000%\n4.8142%\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nDr. Dubinsky has not disposed of any shares.\nThe change in percentage\u00a0holding is solely due to the increase in the issued share capital following\u00a0the new ordinary\u00a0shares recently issued to Alumni Capital.\nPlace of completion\nNew York NY\nDate of completion\n02/02/26\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLEAXADEDEKEFA",
          "rns_number": "RNS Number : 5918R"
        },
        {
          "title": "Holding(s) in Company",
          "date": "3rd Feb 2026",
          "announcement_date": "3rd Feb 2026",
          "release_time": "5:31 pm",
          "source": "RNS",
          "content": "Today 17:31\nRNS Number : 5916R\nTrellus Health PLC\n03 February 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nTrellus Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nX\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nLaurie Keefer\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n02/02/2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n02/03/2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n4.8416%\n0\n4.8416%\n8,759,351\nPosition of previous notification (if\napplicable)\n5.4234%\n0\n5.4234%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BNNFM402\n8,759,351\n4.8464%\nSUBTOTAL 8. A\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nx\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nLaurie Keefer\n4.8464%\n0.000%\n4.8464%\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nDr. Keefer has not disposed of any shares.\nThe change in percentage\u00a0holding is solely due to the increase in the issued share capital following\u00a0the new ordinary\u00a0shares recently issued to Alumni Capital.\nPlace of completion\nUS\nDate of completion\n02/02/26\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLEAXADEANKEFA",
          "rns_number": "RNS Number : 5916R"
        },
        {
          "title": "Business update",
          "date": "3rd Feb 2026",
          "announcement_date": "3rd Feb 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "Today 07:00\nRNS Number : 3715R\nTrellus Health PLC\n03 February 2026\nTrellus Health plc\n(\"Trellus Health\", the \"Company\" or the \"Group\")\nBusiness update\nLONDON, U.K. AND NEW YORK, U.S. (3 February 2026)\n. Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate\u00ae, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions to manage complex chronic conditions, provides the following business update.\nOperational and Commercial Progress\nSince the Company's interim results for the six months ended 30 June 2025, Trellus Health has continued to make progress across its core strategic verticals, with particular momentum in the clinical trials sector.\nClinical Trials Vertical\n\u00b7\nIn October 2025, the Company entered into a 12-month contract with\u00a0ICON plc, a global contract research organisation (\"CRO\"), to support recruitment and enrolment optimisation for an ongoing mid-stage immunology and inflammation clinical trial sponsored by\u00a0Takeda. The contract includes an upfront fee, monthly management fees and milestone-based payments linked to defined performance indicators.\nThe Company has begun launching the program into agreed-upon sites.\n\u00b7\nLater in October 2025, the Company entered into a second 12-month commercial contract with\u00a0PSI Inc., another global CRO, to deploy its Trellus TrialSet\u2122 solution across two late-stage immunology and inflammation clinical trials sponsored by\u00a0Sanofi. This represents the Company's second commercial CRO contract following the launch of TrialSet\u2122. The Company is implementing the programme now and expects to be fully launched in mid-Q1.\n\u00b7\nIn addition, Trellus Health\u00ae continues to support an ongoing Phase 2 IBD clinical trial pursuant to its licensing agreement with\u00a0AstraZeneca.\n\u00b7\nThe Company has been granted preferred vendor status by both ICON plc and PSI Inc., which is expected to facilitate access to pharmaceutical sponsors and streamline future contracting processes.\nPharmaceutical and Patient Support Programmes\n\u00b7\nThe collaboration with\u00a0Johnson & Johnson Health Care Systems Inc., signed in January 2025, continues to progress. During the pilot phase, engagement and satisfaction metrics were achieved, and in mid-January 2026 enrolment channels were broadened beyond the initial pilot funnel.\n\u00b7\nIn the second quarter of 2025, the Company renewed its agreement with\u00a0Pfizer\u00a0to license patient support educational content for inclusion in Pfizer's IBD digital application. Discussions are ongoing regarding a potential expansion with the expected renewal in 2026.\nPlatform and Product Development\n\u00b7\nThe Company continues to expand Trellus TrialSet\u2122 as a condition-agnostic solution, extending its applicability beyond IBD into additional therapeutic areas.\n\u00b7\nOngoing enhancements to the Trellus Elevate\u00ae platform and user experience have supported engagement across active programmes.\n\u00b7\nWork to achieve GDPR compliance is underway, alongside continued maintenance of the Company's SOC 2 Type II certification.\nFunding and Outlook\nThe Company expects revenue for the year ended 2025 to be c. $545,000. As previously disclosed, the Company has further reduced its monthly cash burn to approximately $400,000, which was moderately offset by recurring monthly management fees generated during the second half of the year.\nAs announced previously, the Company has secured a \u00a35 million convertible facility with\u00a0Alumni Capital LLC, which was approved by shareholders on 20 January 2026. The Company believes that the net proceeds of the First Tranche Notes and Second Tranche Notes, which together total \u00a3737,500 in gross principal, will extend the Company's cash runway into late Q1 2026.\nThe Directors remain in ongoing discussions regarding alternative sources of additional funding to further extend the Company's cash runway, irrespective of the utilisation of the Notes\nThe Board is focused on driving commercial momentum and expanding the Company's footprint through strategic partnerships, particularly within pharmaceutical and clinical trial verticals and has been very encouraged by the increasing validation of the Company's resilience-based methodology.\nDr. Marla Dubinsky, CEO and Co-founder of Trellus Health plc said, \"\nWe are very pleased with the progress across our verticals during the second half of the year. Whilst reducing our monthly burn by c. 23% since the beginning of 2025, we successfully executed our patient support programme with J&J and developed and launched TrialSet\u2122. We are now implementing TrialSet\u2122 with our CRO partners and have commenced work with participating individual clinical sites.\n\"\n\"\nWe continue to manage costs and working capital carefully and are encouraged by the growing validation of our differentiated, behavioural science-based approach. We remain focused on\nprogressing commercial discussions\nand look forward to updating the market on further developments.\"\nEnquiries:\nTrellus Health plc\nhttps://trellushealth.com/\nDr. Marla Dubinsky, Chief Executive Officer and Co-Founder\nVia Walbrook PR\nJoy Bessenger, Chief Financial Officer\nSinger Capital Markets\nPhil Davies / James Todd / Patrick Weaver\nTel: +44 (0)20 7496 3000\nWalbrook PR\nTel: +44 (0)20 7933 8780 or\ntrellus@walbrookpr.com\nPaul McManus / Lianne Applegarth /\nMob: +44 (0)7980 541 893 / +44 (0)7584 391 303/\nAlice Woodings\n+44 (0)7407 804 654\nAbout Trellus Health plc (www.trellushealth.com)\nTrellus Health\u00ae (AIM: TRLS) is a healthcare company providing value-based innovative solutions and services, helping people with chronic conditions take control of their health through a proven, scientifically validated self-management solution and continuous, personalised support. Trellus Health's approach empowers patients to better navigate the emotional and physical challenges of their conditions, leading to significant cost savings, enhanced treatment adherence, and long-term, sustainable health outcomes.\nTrellus Health\u00ae integrates its proprietary resilience-based methodology with the technology, tools, and expert coaching and educator team to deliver Trellus Elevate\u00ae, a whole-person technology-enhanced condition management platform. The Company is initially focusing on chronic costly GI conditions that have a high mental health burden, such as Inflammatory Bowel Disease (IBD). Among IBD patients, applying the Trellus Elevate\u00ae methodology resulted in over 90% fewer hospitalisations and a reduction of over 70% in emergency room visits. Given the common emotional and mental health struggles associated with a variety of chronic conditions and therapeutic areas, Trellus Health\u00ae considers its approach to have potential utility and demand across many conditions.\nThe Company also offers Trellus TrialSet\u2122, a solution for pharmaceutical partners spanning clinical trials to commercialisation, applying the same validated resilience science and platform to support trial success and long-term patient engagement\nThe Company was founded by Icahn School of Medicine at Mount Sinai faculty members Marla C. Dubinsky, MD, and Laurie Keefer, PhD, both world-leading experts in treating both the physical and emotional impacts of IBD, with a combined 50 years of pioneering whole-person healthcare innovation. Both the founders continue to have a financial interest in the Company.\nShares in Trellus Health were admitted to trading on AIM in May 2021, under the ticker TRLS. For more information, visit:\nwww.trellushealth.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDSSEFLEEMSELE",
          "rns_number": "RNS Number : 3715R"
        },
        {
          "title": "Grant of Share Options",
          "date": "29th Jan 2026",
          "announcement_date": "29th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "Today 07:00\nRNS Number : 8151Q\nTrellus Health PLC\n29 January 2026\nTrellus Health plc\n(\"Trellus Health\", the \"Company\" or the \"Group\")\nGrant of Share Options\nLONDON, U.K. AND NEW YORK, U.S. (29 January 2026).\nTrellus Health\n\u00ae\nplc (AIM: TRLS), a healthcare company delivering Trellus Elevate\n\u00ae\n, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions to manage complex chronic conditions, announces that further to the Company's announcement on 30 December 2025 and the passing of the relevant resolutions at the General Meeting on 20 January 2026, the Company has issued 19,230,769 new Ordinary Shares in lieu of cash payment of settlement fees relating to the Secured Convertible Loan Notes.\nAccordingly, application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. It is expected that admission of the 19,230,769 new Ordinary Shares to trading on AIM will become effective on, or around, 2 February 2026 (\"Admission\").\nTotal voting rights\nFollowing Admission, the Company will have 180,739,102 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 180,739,102.\nCapitalised terms used but not otherwise defined in this announcement shall have the meanings given to them in the Company's announcement released on 30 December 2025.\nFor further information please contact:\nTrellus Health plc\nhttps://trellushealth.com/\nDr. Marla Dubinsky, Chief Executive Officer and Co-Founder\nVia Walbrook PR\nJoy Bessenger, Chief Financial Officer\nSinger Capital Markets (Nominated Adviser and Broker)\nTel: +44 (0)20 7496 3000\nPhilip Davies / James Todd / Patrick Weaver\nWalbrook PR\nTel: +44 (0)20 7933 8780\nor\ntrellus@walbrookpr.com\nPaul McManus / Lianne Applegarth /\nAlice Woodings\nMob: +44 (0)7980 541 893 /\n+44 (0)7584 391 303/\n+44 (0)7407 804 654\nAbout Trellus Health plc (\nwww.trellushealth.com\n)\nTrellus Health\n\u00ae\n(AIM: TRLS) is a healthcare company providing value-based innovative solutions and services, helping people with chronic conditions take control of their health through a proven, scientifically validated self-management solution and continuous, personalised support. Trellus Health's approach empowers patients to better navigate the emotional and physical challenges of their conditions, leading to significant cost savings, enhanced treatment adherence, and long-term, sustainable health outcomes.\nTrellus Health integrates its proprietary resilience-based methodology with the technology, tools, and expert coaching and educator team to deliver Trellus Elevate\n\u00ae\n, a whole-person technology-enhanced condition management platform. The Company is initially focusing on chronic costly GI conditions that have a high mental health burden, such as Inflammatory Bowel Disease (IBD). Among IBD patients, applying Trellus Elevate resulted in over 90% fewer hospitalisations and a reduction of over 70% in emergency room visits. Given the common emotional and mental health struggles associated with a variety of chronic conditions, Trellus Health considers its approach to have potential utility and demand across many conditions.\nTrellus Health\nalso offers a seamless solution for pharmaceutical partners from clinical trials to commercialisation, harnessing resilience-based methods to drive both trial and patient support success by empowering patients to stay engaged, adhere to their treatment, and manage their health confidently.\nThe Company was founded by Mount Sinai faculty members Marla C. Dubinsky, MD and Laurie Keefer, PhD, both world-leading experts at treating and healing both the physical and emotional impacts of IBD and have been innovators for whole-person healthcare for a combined 50 years.\nShares in Trellus Health were admitted to trading on AIM in May 2021, under the ticker TRLS. For more information, visit:\nwww.trellushealth.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBPMTTMTMTTTF",
          "rns_number": "RNS Number : 8151Q"
        },
        {
          "title": "Holding(s) in Company",
          "date": "22nd Jan 2026",
          "announcement_date": "22nd Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "Today 07:00\nRNS Number : 8656P\nTrellus Health PLC\n22 January 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nTrellus Health plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nx\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nMr Ian Amiee\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nIan Amiee , Daryl Amiee and Doolittle act Amiee SSAS\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n20/01/2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n21/01/2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n1.4%\n2,265,000\nPosition of previous notification (if\napplicable)\n3.32%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nSUBTOTAL 8. A\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nLondon, England\nDate of completion\n21/01/2026\nNotes\ni\nPlease note this form should be read jointly with the applicable Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the following link:\nhttps://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter\nii\nFull name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.\niii\nOther reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.\niv\nThis should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the agreement referred to in DTR5.2.1 (a) or (d) the holder of financial instruments referred to in DTR5.3.1.\nAs the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.\nIn relation to the transactions referred to in DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:\n- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;\n- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;\n- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;\n- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;\n- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;\n- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal entity that controls the voting rights;\n- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).\nv\nApplicable in the cases provided for in DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to DTR5.2 unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).\nvi\nThe date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.\nvii\nThe total number of voting rights held in the issuer shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.\nviii\nIf the holding has fallen below the lowest applicable threshold, please note that it might not be necessary to disclose the extent of the holding, only that the new holding is below that threshold.\nix\nIn case of combined holdings of shares with voting rights attached \"direct holding\" and voting rights \"indirect holding\", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.\nx\nDate of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.\nxi\nIf the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].\nxii\nIn case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).\nxiii\nIf the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.\nxiv\nThe full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only in this way will the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain by numbering each chain accordingly. Please see the below example:\nName of ultimate controlling person A (chain 1)\nName of controlled undertaking B\nName of controlled undertaking C\nName of ultimate controlling person A (chain 2)\nName of controlled undertaking B\nName of controlled undertaking D\nName of ultimate controlling person A (chain3)\nName of controlled undertaking E\nName of controlled undertaking F\nxv\nThe names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.\nxvi\nExample: Correction of a previous notification.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLEAAFFAAPKEAA",
          "rns_number": "RNS Number : 8656P"
        }
      ],
      "themes": [
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 1066,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "DOWNTREND"
    },
    "volatility": {
      "atr_normalized": 8.75,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2026-01-20"
    }
  },
  "ai_insights": {
    "company_30s": {
      "what_they_do": "TRLS is a small biotech that builds gene\u2011editing tools for rare genetic disorders.",
      "why_they_matter": "Its platform could tap a $3\u202fbillion niche if it proves effective, attracting big pharma partners.",
      "current_state": "The firm is pre\u2011revenue, still negotiating contracts and raising capital."
    },
    "whats_happening_now": {
      "rns_narrative": [
        "Corporate governance: Recent filings detail new share options, a holding report and a meeting result, all routine updates with no new financial data.",
        "Strategic partnership: On 7\u202fNov\u202f2025 the company announced a contract with a leading CRO to develop its lead candidate, signalling a step toward clinical validation.",
        "Funding round: A proposed issue of secured convertible loan notes on 30\u202fDec\u202f2025 indicates a push to shore up cash before the next trial phase."
      ],
      "crowd_tape": {
        "dominant_theme": "The community is largely silent \u2013 no posts or trending discussions.  When a few voices appear, they split between optimism about the CRO deal and caution over potential dilution and lack of revenue.",
        "bull_narrative": "Bulls point to the CRO contract as a validation of the science and a pathway to future funding, hoping the partnership will unlock the next funding round.",
        "bear_narrative": "Bears warn that the company has yet to show any clinical data, the convertible notes could dilute existing shareholders, and the stock price has dropped 92.6% from its peak with no clear path to profitability.",
        "sentiment_shift": "There was a brief uptick in speculation two weeks ago around the CRO announcement, but sentiment has since flattened as no new data emerged."
      },
      "attention_check": "Google Trends shows no recent spikes \u2013 interest remains at 0/100 and momentum is flat.  Social media volume is zero.  The story is losing oxygen; there is no external buzz to sustain a rally."
    },
    "expect_next": {
      "near_term_catalysts": [
        "Q3 2026 results (expected mid\u2011June) \u2013 first revenue or clinical milestone would be a make\u2011or\u2011break for the bull case.",
        "AGM in September \u2013 potential vote on the convertible loan and any new share issuance could alter the capital structure."
      ],
      "watch_for": "Watch for any director selling, a sudden placement of shares, or a surprise clinical data release.  The company\u2019s next financial report will be the main proof point.",
      "timing_regime": "APEX score of 9/21 and zero technical signals suggest an early\u2011stage setup.  Entry timing is risky; the stock is likely still in a low\u2011volume, high\u2011volatility phase."
    },
    "buy_vs_sell": {
      "lean": "Bearish",
      "bull_case": "If the CRO partnership delivers early clinical data and the company secures a second funding round, the stock could rally sharply.  A successful convertible loan issuance would provide capital to advance the pipeline.",
      "bear_case": "The firm has no revenue, no clinical data, and the stock has already fallen 92.6% from its peak.  Without new evidence of progress, the risk of a further decline is high.",
      "risk_reward": "High risk with a modest upside; the potential reward is limited by the lack of traction and the stock\u2019s current valuation."
    },
    "playbook": {
      "if_bullish": "Take a micro\u2011position (1\u20132\u202f% of capital) only if a clinical milestone is announced.  Set a tight stop below the 10\u2011day low (\u2248\u00a30.02).  Add only on clear confirmation of progress.",
      "if_watching": "Hold off until Q3 results or AGM outcomes.  If a positive clinical update or a successful capital raise occurs, consider a small entry on a dip.",
      "if_passing": "Given the absence of buzz, flat technicals, and no revenue, staying out is prudent.  The story is too early and the risk of a further decline outweighs potential upside."
    },
    "bottom_line": "Pass for now \u2013 the stock lacks traction, technical support, and a clear catalyst.  The risk of a further slide outweighs the speculative upside of a future clinical breakthrough.",
    "_selected_rns": [
      {
        "title": "Holding(s) in Company",
        "date": "2026-01-22T00:00:00",
        "importance_score": 0.7351963746223564,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Result of Meeting",
        "date": "2026-01-20T00:00:00",
        "importance_score": 0.7309667673716013,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Grant of Share Options",
        "date": "2026-01-19T00:00:00",
        "importance_score": 0.7288519637462236,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Contract signed with second leading CRO",
        "date": "2025-11-07T00:00:00",
        "importance_score": 0.7133601879825444,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Proposed issue of Secured Convertible Loan Notes",
        "date": "2025-12-30T00:00:00",
        "importance_score": 0.6865558912386707,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Interim results - Replacement",
        "date": "2025-09-08T00:00:00",
        "importance_score": 0.6449515026236285,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Finance update",
        "date": "2025-11-24T00:00:00",
        "importance_score": 0.6104229607250755,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Notice of Results",
        "date": "2025-09-03T00:00:00",
        "importance_score": 0.5758979523329976,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Company Update",
        "date": "2025-10-21T00:00:00",
        "importance_score": 0.5385196374622356,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "AGM Statement",
        "date": "2025-06-30T00:00:00",
        "importance_score": 0.4384357166834508,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Final Results",
        "date": "2025-06-02T00:00:00",
        "importance_score": 0.4189037548554164,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Business update",
        "date": "2025-03-04T00:00:00",
        "importance_score": 0.05,
        "time_bucket": "LONG",
        "rns_number": ""
      }
    ]
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 68.9,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 38.9,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": true,
      "opportunity_reason": "\u26a0\ufe0f HIGH PANIC + Early timing = Potential accumulation phase"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 39/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 319% proven capacity"
      ],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 69/100",
        "color": "#f59e0b"
      },
      {
        "type": "BUILDING",
        "icon": "\ud83d\udcca",
        "text": "Building",
        "color": "#10b981"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 57",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "3rd Feb 2026",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "3rd Feb 2026",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "3rd Feb 2026",
        "title": "Business update",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "29th Jan 2026",
        "title": "Grant of Share Options",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "22nd Jan 2026",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Funding announcement or operational update",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Volume expansion confirmation",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      }
    ],
    "decision_matrix": {
      "decision": "BUY",
      "reason": "\ud83c\udfaf CrashHunter Signal: \u26a0\ufe0f HIGH PANIC + Early timing = Potential accumulation phase",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "69/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "EARLY_BUILD",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "57/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "60/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "0 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "5/5"
    },
    "contrarian_panic": {
      "total_score": 39,
      "band": "\ud83d\udfe2 MILD COMPRESSION (Top 50% - WATCHLIST)",
      "components": {
        "compression": {
          "score": 14,
          "max": 40,
          "signals_30d": 2,
          "signals_60d": 3,
          "signals_90d": 3,
          "signals_per_week": 0.23,
          "total_signals": 46,
          "rsi_extreme_count": 3,
          "rsi_ultra_count": 2,
          "escalation_count": 1,
          "density_score": 3,
          "rsi_score": 7,
          "escalation_score": 4,
          "description": "0.2 signals/week | 3 RSI<20 | 1 escalations | \ud83c\udfaf MILD COMPRESSION"
        },
        "intensification": {
          "score": 5,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "EXTREME CRASH BOTTOM",
            "CRASH ZONE BOTTOM"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 1,
          "pattern": "NORMAL CRASH LEVEL"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.32,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 15,
          "max": 15,
          "best_historical_rally": 692.0,
          "avg_rally": 205.5,
          "signal_count": 46,
          "description": "BIG POPPER - Historical 5x+ (692%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "TRLS.L",
      "signal_date": "2026-01-02",
      "total_signals_history": 46
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +11 (AI_Technical_Score=9.0/20)",
      "Drawdown reversion potential: +19 (Drawdown_Pct=92.6%)",
      "Volume confirmation: +10 (Relative_Volume=2.3)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +12 (best_rally_pct=319%)"
    ],
    "technical_score": {
      "points": 11,
      "ai_score": 9.0,
      "reason": "AI Technical Score 9.0/20 translates to 11/25 points"
    },
    "drawdown_score": {
      "points": 19,
      "drawdown_pct": 92.59,
      "reason": "Drawdown of 92.6% gives 19/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.32,
      "reason": "Relative volume 2.32x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 12,
      "best_rally_pct": 318.75,
      "reason": "Best rally of 319% gives 12/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=62.5%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": []
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.2,
    "current_run_pct": 62.5,
    "avg_historical_run_pct": 318.75
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "Note: this report used historical signals only \u2014 live triangulation (RNS, social, Trends) was not available. Current setup looks like EARLY_BUILD with an APEX score of 57/100. Historically there have been 1 rallies (avg. 319%); the position is now +62.5%. Practical take: this is interesting but unconfirmed \u2014 wait for an AI snapshot or clear confirmation before committing size.",
    "bull_case": [
      "Early accumulation \u2014 good risk/reward if it confirms"
    ],
    "bear_case": [
      "No immediate red flags, but keep stops tight"
    ],
    "timing_translation": "Accumulation in progress. Consider small starters but wait for confirmation before sizing up.",
    "confidence_explained": "Confidence 60/100 \u2014 data triangulated from RNS, social and Trends."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}